Top Markets
Coin of the day
Moleculin Biotech, Inc. Moleculin Biotech, Inc.

Moleculin Biotech, Inc.

MBRX
Κατάταξη σε μετοχές #35911
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to... Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to advancing therapeutic candidates designed to combat highly aggressive cancers and viral infections. Their primary investigational drug, Annamycin, is currently undergoing Phase 1/2 clinical trials. These trials aim to assess its efficacy against acute myeloid leukemia (AML) that has relapsed or is resistant to prior therapies, as well as malignancies that have spread to the lungs. WP1066, a prominent immune/transcription modulator for the company, is presently in Phase I studies, targeting both adult and pediatric brain tumors, pancreatic cancer, and other types of aggressive malignancies. Further, the firm is developing WP1220, an analog of WP1066, intended for topical application in treating cutaneous T-cell lymphoma. Another compound, WP1122, is under development for glioblastoma multiforme and COVID-19. Moleculin Biotech has established collaboration agreements and partnerships with organizations such as MD Anderson, Animal Life Sciences, LLC, and WPD Pharmaceuticals Sp z.o.o. The company was founded in 2015 and maintains its principal offices in Houston, Texas.
Τιμή μετοχής
$0.6155
Τελευταίος συγχρονισμός: 2026-08-14
Κεφαλαιοποίηση
$3.28M
Αλλαγή (1 ημέρα)
7.74%
Αλλαγή (1 έτος)
-96.39%
Χώρα
US
Εμπόριο Moleculin Biotech, Inc. (MBRX)

Κατηγορία

Ιστορικό τιμής μετοχής για την Moleculin Biotech, Inc. (MBRX)
Υψηλότερη τιμή κλεισίματος: $0.48 στις 2026-08-01

Χαμηλότερη τιμή κλεισίματος: $16.17K στις 2016-06-01
Ιστορικό τιμής μετοχής της Moleculin Biotech, Inc. από 2016 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) 8.33%
2025 -90.56%
2024 -77.07%
2023 -51.53%
2022 -36.45%
2021 -59.01%
2020 -17.81%
2019 -15.25%
2018 -35.47%
2017 -12.10%
2016 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE